Clinical Trials Browser

Breast Neoplasms

NCT05691465 2026-05-27

Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells

Phase 2 Recruiting

30 enrolled

Genitourinary

Prostatic Neoplasms

NCT03206060 2026-04-24

Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma

Phase 2 Recruiting

130 enrolled

CNSEndocrineNET

Hypertension, Paraganglioma, Pheochromocytoma, Neuroendocrine Tumors

NCT04082520 2026-04-22

Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy

Phase 2 Recruiting

42 enrolled

CNS

Meningioma

NCT04074135 2026-04-20

Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors

Phase 2 Recruiting

740 enrolled

EndocrineGastrointestinalNET

von Hippel-Lindau Disease, Pancreatic Neoplasms, Neuroectodermal Tumors, Primitive, Neuroendocrine Tumors, Multiple Endocrine Neoplasia Type 1

NCT07284589 2026-04-08

Ultralow Dose PET Imaging of SSTR2 Radiotracer Uptake

Phase 2 Recruiting

200 enrolled

Tumor-Agnostic

Neoplasms

NCT04298541 2026-02-27

Direct Comparison of Ga-68-DOTATATE and Ga-68-DOTATOC

Phase 2 Not yet recruiting

6 enrolled

CNS

Meningioma

NCT03448458 2025-07-17

Gallium Ga 68-DOTATATE PET/CT in Diagnosing Patients With Metastatic Castration Resistant Prostate Cancer

Phase 2 Completed

17 enrolled 8 charts

Genitourinary

Prostatic Neoplasms

NCT03602911 2025-03-12

A Comparison of NETSPOT Imaging Versus F-FDG-PET in Head and Neck Cancer Patients

Phase 2 Completed

20 enrolled 5 charts

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT00001277 2022-06-07

Studies of Elevated Parathyroid Activity

Phase 2 Completed

1,553 enrolled 8 charts

EndocrineHead & Neck

Hypercalcemia, Hyperparathyroidism, Hypoglycemia, Multiple Endocrine Neoplasia, Parathyroid Neoplasms

NCT01869725 2021-09-22

Comparative Study of Sensitivity of Ga-DOTATOC PET vs Octreoscan SPECT + CT

Phase 2 Completed

68 enrolled 8 charts

CNSEndocrineNET

Medulloblastoma, Neuroblastoma, Somatostatinoma, Neuroendocrine Tumors

NCT03125629 2021-04-09

Comparison of PET/CT vs. PET/MRI Using 2 Radiopharmaceuticals

Phase 2 Completed

53 enrolled 8 charts

Cancer Diagnosis

NCT01967537 2019-11-19

Evaluation of 68Gallium-DOTATATE PET/CT for Detecting Neuroendocrine Tumors

Phase 2 Completed

341 enrolled 14 charts

EndocrineNET

von Hippel-Lindau Disease, Neuroendocrine Tumors

Clinical Trials

177Lu-DOTATATE for the Treatment of Stage IV or Recurrent Breast Cancer

Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells

Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma

Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy

Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors

Ultralow Dose PET Imaging of SSTR2 Radiotracer Uptake

Direct Comparison of Ga-68-DOTATATE and Ga-68-DOTATOC

Gallium Ga 68-DOTATATE PET/CT in Diagnosing Patients With Metastatic Castration Resistant Prostate Cancer

A Comparison of NETSPOT Imaging Versus F-FDG-PET in Head and Neck Cancer Patients

Studies of Elevated Parathyroid Activity

Comparative Study of Sensitivity of Ga-DOTATOC PET vs Octreoscan SPECT + CT

Comparison of PET/CT vs. PET/MRI Using 2 Radiopharmaceuticals

Evaluation of 68Gallium-DOTATATE PET/CT for Detecting Neuroendocrine Tumors